Comparative plan report · Treatment Planning
Comparative plan report
Sep 4, 2026 · K. Bhatt, CMD · 1 page
G2 › Ferreira, Sam › Treatment Planning › 2026-09-04 Comparative plan report
Rectum V70 2.8% IMPT vs 7.5% VMAT; bladder V65 5.2% vs 10.9%.C-8
Sam Ferreira
Packet ready
72 M · MRN TCPT-0046915 · Prostate adenocarcinoma, favorable intermediate risk, cT1c N0 M0
Humana Gold Plus HMO (Medicare Advantage) · H55120937
Ordered by R. Lee, MD · Sep 2, 2026 · CPT 77523 · C61 Malignant neoplasm of prostate